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SUMMARY
Glycated hemoglobin (HbA1c) is used to classify glycaemia and Type 2 diabetes (T2D). Body 
mass index (BMI) is a predictor of HbA1c levels and T2D. We tested 43 established BMI and 
obesity loci for association with HbA1c in a nationally-representative multiethnic sample of young 
adults from the National Longitudinal Study of Adolescent to Adult Health (Add Health: age 24–
34 years; n = 5,641 EA; 1,740 AA; 1,444 HA) without T2D, using two levels of covariate 
adjustment (Model 1: age, sex, smoking, and geographic region; Model 2: Model 1 covariates plus 
BMI). Bonferroni adjustment was made for 43 SNPs and we considered P < 0.0011 statistically 
significant. Means (SD) for HbA1c were 5.4%(0.3) in European Americans (EA), 5.7%(0.4) in 
African Americans (AA), and 5.5%(0.3) in Hispanic Americans (HA). We observed significant 
evidence for association with HbA1c for two variants near SH2B1 in EA (rs4788102, P = 
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2.2×10−4; rs7359397, P = 9.8×10−4) for Model 1. Both results were attenuated after adjustment for 
BMI (rs4788102, P = 1.7×10−3; rs7359397, P = 4.6×10−3). No variant reached Bonferroni-
corrected significance in AA or HA. These results suggest that SH2B1 polymorphisms are 




Diabetes prevalence has risen substantially over the last few decades, disproportionately 
affecting race/ethnic minorities (Cowie et al. 2009, Cowie et al. 2010). In 2012, 29 million 
Americans had diabetes; over 8 million were undiagnosed (Centers for Disease Control and 
Prevention 2014). The total cost of diabetes in 2007 was estimated to be $245 billion 
(Centers for Disease Control and Prevention 2014) and this economic burden is likely to 
escalate over time. The adverse health and economic consequences, combined with 
significant race/ethnic disparities and high rates of undiagnosed diabetes, emphasize the 
critical need to address this disease.
Glycated hemoglobin (HbA1c) is a marker of long-term glycemic control and is a diagnostic 
measure to classify glycaemia and type 2 diabetes (T2D) (American Diabetes Association 
2013). HbA1c has been shown to have a substantial genetic component, with heritability 
estimated at 75% (Simonis-Bik et al. 2008). Body mass index (BMI) is a strong predictor of 
HbA1c and T2D (The et al. 2013), especially in younger age groups (Awa et al. 2012; 
Schienkiewitz et al. 2006; Abdul-Ghani et al. 2005; Hillier and Pedula 2001). Large-scale 
genome wide association studies (GWAS) for BMI have identified multiple loci that have 
been widely replicated (Liu et al. 2014; Yoneyama et al. 2014; Graff et al. 2013; Monda et 
al. 2013; Speliotes et al. 2010; Thorleifsson et al. 2009; Willer et al. 2009; Heard-Costa et al. 
2009; Loos et al. 2008; Frayling et al. 2007). Some of the genetic loci identified for BMI, 
including SH2B1, have also later been found to be associated with HbA1c (Sandholt et al. 
2011; Fall et al. 2012; Mutombo et al. 2014). The majority of genetic studies of BMI and 
other metabolic traits, however, have focused on adult populations. Much less is known 
about how genetic loci are associated with metabolic traits such as HbA1c in young 
adulthood, a life period which may be particularly sensitive with respect to the development 
of T2D given that substantial decreases in insulin sensitivity occur during pubertal 
development (Moran et al. 1999). An interesting question is whether variants associated with 
BMI in adults are associated with HbA1c levels in young adults, and whether these effects 
are independent of BMI.
In the current study, we evaluated the associations between 43 single nucleotide 
polymorphisms (SNPs) from 41 well-established BMI- and obesity-associated gene regions 
and HbA1c in the National Longitudinal Study of Adolescent Health (Add Health), a 
nationally representative sample of European-American (EA), African-American (AA) and 
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Hispanic-American (HA) young adults (24 – 34 years of age at time of HbA1c 
measurement). We further tested whether any observed associations were mediated by BMI.
METHODS
Study Sample
The National Longitudinal Study of Adolescent Health (Add Health) study is a national, 
prospective cohort study of adolescents representative of the U.S. school-based population in 
grades 7 to 12 (11–22 years of age) in 1994–95 (wave I, n = 20,745) who are followed over 
three waves into adulthood (wave II: 1996, 12–21 years (n = 14,738); wave III: 2001–2002, 
18–27 years (n = 15,197); wave IV: 2008–2009, 23–32 years (n = 15,701). DNA was first 
collected from all respondents at wave IV, and consent given for banking and use in future 
genetic studies (n = 12,234). Add Health included a core sample plus subsamples of selected 
minorities, related adolescents (n = 5,524), and other groups, including well-educated AAs, 
collected under protocols approved by the Institutional Review Board at the University of 
North Carolina at Chapel Hill. The survey design and sampling strategy have been described 
previously (Resnick et al. 1997; Miller et al. 2004; Harris 2010).
Analytic Sample
At wave IV, 58% (n = 12,066) of wave I (n = 20,745) respondents provided DNA samples 
with consent for banking and use in future genetic studies. To be eligible for the current 
study, each individual had to have at least 80% of their SNPs genotyped and have measures 
of HbA1c (n = 10,943). We excluded the participants meeting one or more of the following: 
the monozygotic twin with fewer genotyped loci within each twin pair (n = 310), pregnant (n 
= 313) or disabled (n = 27) individuals, those reporting Native American (n = 56), Asian (n 
= 519), or ‘other’ race (n = 90), those with a self-reported diagnosis of diabetes (n = 332), 
taking diabetic medications (n = 33) or with HbA1c ≥ 6.5% (n = 318), and those with 
missing data for: geographic region (n = 65), BMI (n = 18), race (n = 39), or current 
smoking (n = 25). The final analytic sample was n = 8,825 from 8,083 households (7,383 
singletons, 659 sibling pairs, 40 sibling trios and 1 family with four siblings).
Race/ethnicity
Because genetic biomarkers to determine ancestry were unavailable, we used a race/
ethnicity variable constructed from respondent and parental survey items on ancestral 
background and family relationship status, creating a race/ethnicity variable with priority for 
agreement between participant and parental report. We used a three-category classification: 
non-Hispanic EA, non-Hispanic AA and HA with indicators for subpopulation (e.g. 
Mexican, Cuban) and immigrant status (e.g. US and non-US born).
Anthropometry
Height and weight were measured via standardized protocol, with body mass index (BMI) 
derived using weight in kg/height in meters squared.
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At wave IV, diabetes was identified using self-reported previous diagnosis and HbA1c from 
whole blood spot assays collected from finger pricks that were assayed at University of 
Washington Department of Laboratory Medicine (UW Lab Med, Mark H. Wener, M.D., 
Director, Seattle, WA). Finger prick measures have achieved the same level of precision and 
reproducibility as other standard methods of collecting blood such as venipuncture 
(Tamborlane et al. 2005). Diagnosed diabetes (type 1 or type 2) was defined as a “yes” 
response to the question “Has a doctor, nurse or other health provider ever told you that you 
have or had high blood sugar or diabetes [if female, when you were not pregnant]?” 
Undiagnosed diabetes was defined in Add Health as a “no” response to the previous 
question and an HbA1c≥6.5%, as previously described (The et al. 2013; Attard et al. 2013).
SNP Selection
SNPs were selected based on BMI and obesity results from the Genome-wide Investigation 
of ANThropometric measures (GIANT) consortium and other studies in European adults 
(Speliotes et al. 2010; Thorleifsson et al. 2009; Willer et al. 2009; Heard-Costa et al. 2009; 
Frayling et al. 2007). We pruned SNPs using an r2 criterion of 0.80 (using HapMap CEU, 
YRI and CHB data). Based on this pruning, we selected a set of 43 SNPs representing 41 
EA established regions in or near genes. For AA, we excluded 16 of 43 SNPs (indicated 
with NA in Table 2) that did not show evidence of association at P < 0.20 and consistent 
direction of effect for BMI in a large AA GWAS meta-analysis of adults (Monda et al. 2013; 
Kang et al. 2010). Given the lack of a large GWAS in Hispanics, and the observation that 
75% of GWAS SNPs for complex traits were replicated in Hispanics, all 43 SNPs were 
considered for HA (Carlson et al. 2013).
Genotyping
DNA from saliva was used for genotyping. Forty-three established BMI and obesity SNPs 
were genotyped using TaqMan, using procedures described previously (Graff et al. 2012). 
SNPs were measured from the following 41 regions: ADCY9, BDNF, CADM2, ETV5, 
FAIM2, FANCL, FLJ3577, FTO, GNPDA2, GPRC5B, KCTD15, LMX1B, LRP1B, 
LRRN6C, LYPLAL1, LZTR2, MAF, MAP2K5, MC4RI (2), MSRA, MTCH2, MTIF3, 
NCR3/BAT2, NEGR1, NPC1, NRXN3, NUDT3, POMC, PRKD1, PRL, PTBP2, PTER, 
QPCTL, RPL27A, SEC16B, SH2B1/APOB (2), SLC39A8, TFAP2B, TMEM160, 
TMEM18, TNNI3K. The overall discordance rate across SNPs was 0.3%, and the average 
call-rate was 97.9%.
Statistical Analysis
Race-stratified linear mixed models, including two non-nested random effects for school and 
family, were used to test for associations with HbA1c. We first tested whether BMI was 
associated with HbA1c, by ancestry group, after adjusting for age, sex, smoking status and 
geographic region. Given prior reports, we also tested whether the effect of BMI on HbA1c 
differed by age by testing a BMI × age interaction. We then tested for evidence of 
association between each SNP and HbA1c in models stratified by race/ethnicity. Genotype 
was modeled as an additive effect. Two levels of covariate adjustment were used: Model 1 
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included adjustment for age, sex, smoking, and geographic region and Model 2 further 
included BMI. Covariates are from the same visit as HbA1c, which was measured at wave 
IV. Additional covariate adjustments in AA models (an indicator variable for the 
oversampling of highly educated AAs (n = 355)) and in HA models (indicator variables for 
Cuban (n= 193), Puerto Rican (n = 224), Central/South American (n =120), Mexican (n = 
660), or other Hispanic (n = 103) ancestry; an indicator variable for being foreign born (n 
=268)). Bonferroni adjustment was made for 43 SNPs; P < 0.0011 was considered 
statistically significant.
RESULTS
The analysis sample included 5,641 EA, 1,444 HA and 1,740 AA Add Health participants 
with genotype and HbA1C data. Sample descriptives are given in Table 1. BMI was 
significantly positively associated with HbA1c in all three ethnic groups (EA: P = 
2.8×10−89; HA: P = 5.2×10−28; AA: P = 1.3×10−31). There was a trend supporting stronger 
effects of BMI on HbA1c in younger age groups in EAs (Pinteraction= 0.054) and AAs 
(Pinteraction = 0.094) (data not shown). Genetic effect alleles and effect allele frequencies for 
each ethnic group are given in Table 2 and genetic association test results are given in Table 
3.
For Model 1 adjustment, two of the 43 SNPs tested were significantly associated with 
HbA1c in EAs after multiple test correction (P < 0.0011). Both variants are near the SH2B1/
APOB locus: rs4788102 (P = 2.2×10−4) and rs7359397 (P = 9.8×10−4). SNPs in CADM2 
(rs13078807; P = 0.03), MTCH2 (rs3817334; P = 0.02) and NEGR1 (rs2568958; P = 0.01) 
were nominally associated (P < 0.05) with HbA1c in EAs. After additional adjustment for 
BMI (Model 2), all associations with HbA1c were attenuated and no variants remained 
significantly associated with HbA1c after multiple test correction. Three variants were 
nominally significant after Model 2 adjustment in EAs: SH2B1/APOB rs4788102 (P = 
0.0017) and rs7359397 (P = 0.0046), and NEGR1 rs2568958 (P = 0.04). The two SH2B1/
APOB SNPs, rs4788102 and rs7359397, are highly correlated in EAs (R2 = 0.97 using 1000 
Genomes CEU).
No variants were significantly associated with HbA1c for either Model 1 or Model 2 
adjustment, after multiple test correction, for either the HAs or AAs. Three SNPs were 
nominally significantly associated with HbA1c in HAs: ADCY9 rs2444217 (P = 0.013), 
LMX1B rs867559 (P = 0.0056), and NPC1 rs1805081 (P = 0.010). P-values remained 
similar for all three SNPs after additional adjustment for BMI. One variant was nominally 
associated with HbA1c in AAs: SEC16B rs10913469 (P = 0.02). This variant became 
slightly more significant (P = 0.0068) after additional adjustment for BMI in Model 2. In 
addition, SH2B1/APOB variant rs4788102 was nominally associated with HbA1c (P = 0.02) 
after BMI adjustment, in AAs. We note, however, that the estimated direction of effect of 
this SNP for AAs was opposite of that observed in the EAs. There was no evidence for 
association between either of the SH2B1/APOB SNPs and HbA1c in HAs or for SH2B1/
APOB SNP rs7359397 in AAs (all P > 0.4). There also was no evidence for association 
between variants that were nominally significant in one ethnicity (EAs: CADM2 
rs13078807, MTCH2 rs3817334 and NEGR1 rs2568958; HAs: ADCY9 rs2444217, 
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LMX1B rs867559 and NPC1 rs1805081; AAs: SEC16B rs10913469) and HbA1c in any of 
the other ethnicities (all P > 0.1).
DISCUSSION
HbA1c is a quantitative measure of glucose control. The American Diabetes Association 
(2013) has included HbA1c ≥ 6.5% as a criterion for the diagnosis of T2D. BMI is a major 
predictor of glucose levels and T2D (Felber & Golay 2002; Hekimsoy & Oktem 2003; 
Everhart 1992; Wanamethee & Shaper 1999; Sakurai et al. 1999; Pontiroli & Galli 1998; 
Schienkiewitz et al. 2006; Kahn et al. 2006). The incidence rate of T2D in young adults has 
risen dramatically during the past couple of decades and much of that increase is directly 
attributed to the growing obesity epidemic in young people (Kaufman 2002). Previously, we 
reported the generalization of EA identified genetic effects for 43 obesity related variants 
with BMI in our multi-ethic population of young adults participating in Add Health (Graff et 
al. 2012). Herein, we assessed the association of these same variants with HbA1c, both 
before and after controlling for BMI. We identified significant associations for two variants 
in SH2B1 in EAs (rs4788102, β = 0.021, P = 2.2×10−4; rs7359397, β = 0.018, P = 9.8×10−4) 
before adjustment of BMI. After adjustment for BMI, the statistical significance and 
estimated beta coefficients (for each additional effect allele – see Table 2) were modestly 
attenuated (rs4788102, β = 0.017, P = 1.7×10−3; rs7359397, β = 0.015, P = 4.6×10−3). Of 
note, both rs4788102 (P = 0.014) and rs7359397 (P = 0.034) were nominally associated with 
BMI in the EA analytic Wave IV sample. Effect estimates for these two SNPs on BMI were 
similar to EAs in both HAs and AAs (rs4788102: β = 0.33 in EAs, β = 0.25 in HAs and β = 
0.29 in AAs; rs7359397: β = 0.28 in EAs, β = 0.20 in HAs and β = 0.24 in AAs), but the 
results were not statistically significant.
SH2B1, or SH2B Adaptor Protein 1, has been a strong candidate for metabolic disorders due 
to its involvement in leptin and insulin signaling (Maures et al. 2007). SH2B gene −/− 
knockout mice have been shown to develop age-dependent hyperinsulinemia, 
hyperglycemia, and glucose intolerance, where insulin resistance was more severe in older 
mice (Duan et al. 2004). A more recent study identified SH2B1 as a regulator of insulin 
expression in mice. Chen et al. (2014) observed that leptin-deficient ob/ob mice with a 
heterozygous deletion of SH2B1 were characterized by decreased pancreatic insulin content 
and plasma insulin levels, thus exacerbating hyperglycemia and glucose intolerance. In 
humans, rare SH2B1 deletions and mutations have been observed in obese individuals with 
extremely high insulin resistance. SH2B1 is one of a set of genes that is disrupted in patients 
with a syndrome defined by a 220-kb deletion of chromosome 16p11.2 and characterized by 
obesity and severe insulin resistance disproportionate for the degree of obesity (Bochukova 
et al. 2010).
Association results between common SH2B1 variants and measures of insulin resistance and 
glucose tolerance in epidemiologic studies have been mixed. In a study of 15 previously 
identified overweight and obesity genes conducted in ~18K Danish adults, Sandholt et al. 
(2011) reported a nominally significant BMI-independent association between missense 
SH2B1 SNP, rs7498665 (Thr484Ala), and risk of T2D (P = 7.8 × 10−4). Rs7498665 is in 
strong linkage disequilibrium (LD) with our two studied variants in EAs (R2 = 1, D’ = 1 
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with rs4788102; R2 = 0.97, D’ = 1 with rs7359397) based on HapMap CEU data. A two-
stage study initially evaluated 32 obesity variants in n = 926 non-diabetic 71 year-old men 
from Sweden for association with insulin index. The authors found evidence for association 
at SH2B1 rs7359397 (P = 0.01). They then followed up this result by testing and finding an 
association between this SNP and a homeostasis model assessment of insulin resistance in 
the Meta-Analyses of Glucose and Insulin-related traits (MAGIC) Consortium (n = 37,037; 
P = 0.0039) (Fall et al. 2012). A separate 2013 European meta-analysis of over 93,000 
adults, however, found no evidence for an association between SH2B1 rs4788102 genotype 
and abnormal glucose homeostasis, defined by impaired fasting glucose, impaired glucose 
tolerance or T2D (odds ratio = 1.01; 95% confidence interval: 0.98 – 1.05) (Prudente et al. 
2013). There were considerable differences across cohorts with respect to the measure of 
hyperglycemia used in this meta-analysis and the authors found considerable heterogeneity 
of the association results across studies. Further complicating the interpretation of their 
results, in the context of our own findings, glucose homeostasis was analyzed as a 
dichotomous trait and included both diabetics and non-diabetics. The authors noted the 
association between SH2B1 genotype and hyperglycemia appeared to be stronger in 
individuals with lower BMI, which would be consistent with younger populations. It is 
important to note that all studies to date have largely focused on older adults and results may 
not reflect the relationship between glucose homeostasis and SH2B1 variants in younger 
adults. Evidence suggests that elevated BMI is a particularly important risk factor for early 
T2D (Awa et al. 2012; Abdul-Ghani et al. 2005; Hillier and Pedula 2001); hence, study of 
BMI associated SH2B1 SNPs in younger adults could provide important new insight into the 
etiological role of SH2B1, or nearby coded proteins, in T2D.
Rs4788102 is an intergenic SNP that maps ~2Kb 5′ of SH2B1 while rs7359397 is an 
intergenic SNP that maps just outside the 3′UTR of SH2B1. In our study, the two SNPs 
have highly correlated genotypes in EAs (R2 = 0.97) and HAs (R2 = 0.91), but much weaker 
correlation in AAs (R2 = 0.25). Both SNPs are in the same wide LD block with reported 
missense variant rs7498665 in populations of European and Hispanic descent (only 
rs4788102 is in the same LD block with rs7498665 in AAs) and neither SNP has a known 
function. While we found evidence for association between these SNPs and Hb1Ac in 5,641 
EA young adults, we did not find any such evidence in HAs (n = 1,373). We observed 
nominal evidence for an association with rs4788102 in AAs (n = 1,641, P = 0.02 after 
adjustment for BMI), but the effect was in the opposite direction as in EAs. Rs7359397 is 
not polymorphic in YRI HapMap participants, while rs4788102 and rs7498665 are in perfect 
LD in YRI HapMap participants (R2 = 1, D’ = 1). Of note, based on HapMap CEU and YRI 
data, a relatively common haplotype carrying the minor alleles at rs4788102 and rs7359397 
in CEU is completely absent in YRI. Thus, the observed nominal association at rs4788102 
with a different direction of effect in AAs could be due to different haplotype structures in 
EAs and AAs tagging a common unknown causal variant(s), rs4788102 tagging a different 
causal variant(s) in AAs or a type I error (e.g. due to uncorrected population stratification). It 
should be noted that SNPs were selected for this study based on GWAS for BMI performed 
in populations of European ancestry and some SNP associations with BMI may not be 
generalizable to non-European populations. Further, our considerably smaller sample sizes 
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for HAs and AAs resulted in lower power to detect true effects in these populations relative 
to our power in EAs.
In summary, we identified a significant association between common SH2B1 SNPs 
rs4788102 and rs7359397 and HbA1c in 5,641 EA young adults. These associations were 
only partially mediated by BMI. These same SH2B1 common variants have been established 
to be associated with BMI in older populations of European descent. The relationship 
between SH2B1 and glycated hemoglobin related traits has been widely studied, with animal 
models and human studies of rare functional mutations showing a clear role for SH2B1. 
Results from previous human epidemiological studies of common variants in or near SH2B1 
have been less conclusive. A wide range of human studies has provided conflicting evidence 
regarding the association between these variants and glycated hemoglobin traits. Our study 
is unique in that is focuses entirely on young adults, a population understudied for metabolic 
related traits. Given the observed heterogeneity of effects of SH2B1 genotypes on glycated 
hemoglobin traits in the literature, future follow-up studies of young adults would be ideal 
for replication of our findings.
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